Cough sedative medicine
Indications
Recotuss sedative is a medicine used in the symptomatic treatment of cough.
Composition
Active ingredients
1 ml of syrup contains 2.0 mg of dextromethorphan hydrobromide (equivalent to 1.541 mg of dextromethorphan).
Excipients with known effects: Sucrose, ethanol and methyl p-hydroxybenzoate.
Excipients
Ethanol Sorbitol solution Sucrose Glycerol Methyl para-hydroxybenzoate Lemon flavour Mint flavour Purified water
Directions for use and Dosage
- Adults: one measuring spoon (mark "5 ml" of the measuring spoon included in the package) three to four times a day. Do not exceed the recommended dose;
- Children over two years of age: half a measuring spoon (the "2.5 ml" mark on the measuring spoon included in the package) three to four times a day.
Warnings
After 5 to 7 days of treatment without appreciable results, consult your doctor. Dextromethorphan should be used with caution in debilitated patients. The product is not recommended for asthmatic patients.
Cases of dextromethorphan abuse have been reported. Particular caution is recommended with adolescents and young adults, as well as with children. with patients with a history of drug or psychoactive substance abuse.
Paediatric population: In children under two years of age, the preparation should be administered only if clearly needed and under direct medical supervision. Dextromethorphan is metabolized by the hepatic cytochrome P450 2D6. The activity of this enzyme is genetically determined. Approximately 10% of the population metabolizes CYP2D6 slowly.
Poor metabolizers and patients concomitantly using CYP2D6 inhibitors may experience exaggerated and/or prolonged effects of dextromethorphan. Therefore, caution is required in patients who are poor metabolizers of CYP2D6 or who use CYP2D6 inhibitors (see also section 4.5). Recotuss Sedative contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine.
Contraindications
Hypersensitivity to the active substance or to other chemically related substances, or to any of the excipients listed in section 6.1. Do not administer during or within two weeks of therapy with antidepressants.
Side effects
Drowsiness, gastrointestinal disturbances (nausea, vomiting), and dizziness may occur during therapy. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Overdose
Symptoms of overdose may include mental confusion and strong excitement. High doses may induce respiratory depression.
Pregnancy and breastfeeding
In pregnant women, the preparation should be administered only if clearly necessary and under the direct supervision of a doctor.
Format
100 ml
Product Code:FRCM172144
Richiedi info sul prodotto
